| Literature DB >> 31717489 |
Megan Culbreth1, Michael Aschner2.
Abstract
Methylmercury (MeHg) has conventionally been investigated for effects on nervous system development. As such, epigenetic modifications have become an attractive mechanistic target, and research on MeHg and epigenetics has rapidly expanded in the past decade. Although, these inquiries are a recent advance in the field, much has been learned in regards to MeHg-induced epigenetic modifications, particularly in the brain. In vitro and in vivo controlled exposure studies illustrate that MeHg effects microRNA (miRNA) expression, histone modifications, and DNA methylation both globally and at individual genes. Moreover, some effects are transgenerationally inherited, as organisms not directly exposed to MeHg exhibited biological and behavioral alterations. miRNA expression generally appears to be downregulated consequent to exposure. Further, global histone acetylation also seems to be reduced, persist at distinct gene promoters, and is contemporaneous with enhanced histone methylation. Moreover, global DNA methylation appears to decrease in brain-derived tissues, but not in the liver; however, selected individual genes in the brain are hypermethylated. Human epidemiological studies have also identified hypo- or hypermethylated individual genes, which correlated with MeHg exposure in distinct populations. Intriguingly, several observed epigenetic modifications can be correlated with known mechanisms of MeHg toxicity. Despite this knowledge, however, the functional consequences of these modifications are not entirely evident. Additional research will be necessary to fully comprehend MeHg-induced epigenetic modifications and the impact on the toxic response.Entities:
Keywords: DNA methylation; epigenetics; histone modifications; methylmercury (MeHg); microRNA (miRNA); transgenerational inheritance
Year: 2019 PMID: 31717489 PMCID: PMC6958348 DOI: 10.3390/toxics7040056
Source DB: PubMed Journal: Toxics ISSN: 2305-6304
Methylmercury-induced epigenetic modifications in vitro.
| Epigenetic Modification | Model | Effect | Dose and Duration | Reference |
|---|---|---|---|---|
|
| rat cortical neurons | decreased miR-206 expression | 1 μM MeHg for 12 or 24 h | [ |
| carcinoma, pluripotent human stem cell-derived neurons and glial cells | increased miR-302b, miR-367, miR-372, miR-196b, and miR-141 expression | 400 nM MeHg during neuronal differentiation (day 2 to 36 in vitro) | [ | |
| immortalized human embryonic neural progenitor cells | decreased miR-1285, miR-25, and miR-30d expression | 50 nM MeHg for 24 h | [ | |
|
| Human fetal brain-derived immortalized cells | increased H3K27 trimethylation at TH promotor | 1 nM MeHg during neuronal differentiation (day 2 to 8 in vitro) | [ |
| SH-SY5Y human neuroblastoma cells | decreased global H4 acetylation | 1 μM MeHg for 24 h | [ | |
| SH-SY5Y human neuroblastoma cells | increased HDAC4 mRNA, protein, and binding to BDNF promotor | 1 μM MeHg for 24 h | [ | |
| rat cortical neurons | increased HDAC4 protein | 1 μM MeHg for 24 h | ||
|
| rat cortical neural stem cells | decreased global DNA methylation; decreased DNMT-3b mRNA | 2.5 or 5 nM MeHg for 48 h | [ |
Methylmercury-induced epigenetics modifications in vivo.
| Epigenetic Modifications | Model | Effect | Dose and Duration | Reference |
|---|---|---|---|---|
|
| zebrafish | decreased dre-miR-7147 and dre-miR-26a; increased dre-miR-375 and dre-miR-206 expression | microinjected 48 hpf embryos with 0.01 mg/ml MeHg for 24 h | [ |
|
| decreased miR-37-3p, miR-41-5p, miR-70-3p, and miR-75-3p expression | 10 μM MeHg from embryo to L4 stage | [ | |
|
|
| increased H3K4 trimethylation | 10 μM MeHg to L1 to L4 stage | [ |
| adult male C57Bl/6 mice (neural) | decreased H4 acetylation | subcutaneous injection of 10 mg/kg MeHg for 10 days | [ | |
| C57Bl/6 mice (neural) | increased H3K27 trimethylation and decreased H3 acetylation at BDNF promotor | dams exposed to 0.5 mg/kg MeHg in drinking water from GD 7 to PND 7 | [ | |
| hypermethylation of BDNF promotor | ||||
|
| juvenile male mink (neural) | decreased global DNA methylation | 0.1–2 mg/kg in diet for 3 months | [ |
| decreased DNMT activity | 0.5–2 mg/kg in diet for 3 months | |||
| Sprague-Dawley rats (hepatic) | decreased DNMT-1 and DNMT-3b mRNA; no effect on global DNA methylation | dams exposed from GD 1 to PND 21 in diet to 2 mg/kg MeHg | [ | |
| adult female Wister rats (nephro) | hypomethylation of exon 1 of MMP9; increased MMP9 mRNA and protein | 0.5 or 5 ppm MeHg for 28 days by oral gavage | [ | |
| zebrafish (hepatic) | no effect on global DNA methylation | adult females fed 10 mg/kg in diet for 47 days | [ |
Methylmercury effects on transgenerational inheritance.
| Model | Effect | Dose and Duration | Reference |
|---|---|---|---|
| CD-1 mice |
matrilineally descended F2 and F4 males had elevated blood glucose matrilineally descended F2, F3, and F4 males had higher abdominal adipose tissue weights; increased IRS1 phosphorylation at Ser307 matrilineally and patrilineally F2 descended females had increased kidney weight | adult female mice subcutaneously injected with combination cadmium and MeHg (2 mg/kg) from 4 days before to 4 days after conception | [ |
| zebrafish |
visual deficits and hyperactivity in F2 increased potassium current amplitude in F2 increased sperm epimutations (30 nM) in F2 | embryos exposed to 0, 1, 3, 10, 30, or 100 nM MeHg until 24 hpf | [ |
| zebrafish |
no difference in avoidance response or crossing latency at 0.1 μM from controls in F2 and F3 no difference in avoidance response or crossing latency at 0.01 μM from controls in F2 | embryos exposed to 0, 0.01, 0.10 μM MeHg from 2 to 24 hpf | [ |
| zebrafish |
no effect on global DNA methylation in F0, F1, or F2 liver some genes hypo- or hypermethylated in F1, and 1 gene hypermethylated in F2 no effect on SEPP1 expression across F0–F2 | adult females fed 10 mg/kg MeHg in diet for 47 days | [ |
Methylmercury effects on DNA methylation in human populations.
| Population | MeHg Measurement | Effect | Reference |
|---|---|---|---|
| newborns (Baltimore, MD, USA) | cord blood | MeHg concentration associated with overlapping DMR within TCEANC2 | [ |
| mother-infant pairs (USA) | maternal toenail | associated with hypermethylated north shore regions of CpG islands | [ |
| mother-child pairs (Massachusetts, USA) | maternal blood | associated with lower regional cord blood DNA methylation at PON1 in males at 2.9–4.9 years | [ |
| dental professionals (Michigan, USA) | hair and urine | hair Hg associated with | [ |
| women undergoing IVF (San Francisco, CA, USA) | hair and urine | associated with | [ |
| Faroese birth cohort | cord blood and maternal hair | no CpG site methylation changes associated with cord blood; 5 CpG site methylation changes associated with maternal hair | [ |
| infants (Rhode Island, USA) | infant toenail | associated with | [ |